Physician profile
Thomas J Johnson
NPI 1942214143
$1,228.12
in general payments reported to CMS, 2019-2025
19 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $19.23 · 2021: $241 · 2022: $324 · 2023: $110 · 2024: $155 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.51 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $263.64 | 2019-2025 | Clareon, Rocklatan |
| Notal Vision, INC. | $183.02 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $147.36 | 2024-2025 | Xdemvy |
| Ivantis, INC | $115.20 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $86.55 | 2022-2024 | Acuvue |
| Horizon Therapeutics Plc | $83.12 | 2021-2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $60.21 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $40.12 | 2023-2025 | Xipere, Miebo |
| Shire North American Group INC | $32.02 | 2019 | |
| Amgen INC. | $30.21 | 2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $28.94 | 2025 | Acthar |
| Apellis Pharmaceuticals, INC. | $24.42 | 2025 | Syfovre |
| Rxsight INC | $23.59 | 2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Allergan, INC. | $22.91 | 2022 | |
| Sight Sciences, INC. | $19.23 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $18.57 | 2023 | |
| Biotissue Holdings INC. | $18.02 | 2022 | |
| Abbvie INC. | $16.51 | 2023 | |
| Staar Surgical Company | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.